ArticleHead and neck pathology2014
Envisioning the next WHO head and neck classification.
Article in Head and neck pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 43 citations in OpenAlex.
- Sinonasal renal cell-like adenocarcinoma: a case report and literature review.Diagnostic pathology · 2026Review
- Comprehensive survival analysis of oral squamous cell carcinoma patients undergoing initial radical surgery.BMC oral health · 2024Article
- Intraductal carcinoma of right parapharyngeal space presenting as a fluctuant swelling of retromolar region: Case emphasizing on the histological differential diagnosis.Journal of oral and maxillofacial pathology : JOMFP · 2023Article
- Sinonasal Renal Cell-Like Adenocarcinoma.Cureus · 2021Article
- Imaging Review of New and Emerging Sinonasal Tumors and Tumor-Like Entities from the Fourth Edition of theAJNR. American journal of neuroradiology · 2019Review
- Local recurrence of sinonasal renal cell-like adenocarcinoma: A CARE compliant case report.Medicine · 2019Article
- Renal cell -like carcinoma of the nasal cavity: a case report and review of the literature.Diagnostic pathology · 2017Review
- Sinonasal Renal Cell-Like Carcinoma: Case Report and Review of the Literature.Head and neck pathology · 2017Review
- Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Nasal Cavity, Paranasal Sinuses and Skull Base.Head and neck pathology · 2017Article
- Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Preface.Head and neck pathology · 2017Article
- Newly Described Tumor Entities in Sinonasal Tract Pathology.Head and neck pathology · 2016Review
- Low-Grade Epithelial Proliferations of the Sinonasal Tract.Head and neck pathology · 2016Review
- Plectin as a prognostic marker in non-metastatic oral squamous cell carcinoma.BMC oral health · 2015Article
- Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2015Article
- Salivary Gland Hyalinizing Clear Cell Carcinoma.Journal of pathology and translational medicine · 2015Article
- Impact of smoking on pathological features in oral cavity squamous cell carcinoma.Journal of cancer research and therapeuticsArticle
- Low-grade intraductal carcinoma of salivary glands: A systematic review of this rare entity.Journal of oral biology and craniofacial researchReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The next WHO classification should abandon "salivary duct carcinoma"; conventional salivary duct carcinoma should be classified as "high-grade salivary duct carcinoma". Low-grade salivary duct carcinoma should replace the current nosology of "low-grade cribriform cystadenocarcinoma". Cystadenocarcinoma should be classified with the descriptor "Not Otherwise Specified" and should be considered an exclusionary diagnostic category. On the other hand, "Not Otherwise Specified" does not fit for hyalinizing clear cell carcinoma (HCCC). The EWSR1-ATF1 fusion is specific for HCCC within the context of salivary neoplasia. We recommend adding "hyalinizing" even though this feature is not present in all cases; the benefit of which is the mental association with a salivary clear cell malignancy. Sinonasal Renal Cell-like Adenocarcinoma (SNRCLA) is a distinct clear cell neoplasm and should be added to the next WHO classification. Future studies will bear out whether SNRCLA is even a low-grade carcinoma, or may be reclassified as "adenoma". Lastly, the next WHO monograph should include the Risk Model in the general introductory statements on oral squamous cell carcinoma, under a subheading of "Histological Prognosticators". The positive predictive value for developing locoregional recurrence in patients with low-stage oral cavity squamous carcinoma (OSCC) and "worst pattern of invasion type-5" (WPOI-5) is 42 %. Low-stage high-risk OSCC with a combination of features other than WPOI-5 is associated with 32 % likelihood for locoregional progression. WPOI-5 also predicts occult metastatic disease (p = 0.0001, Chi squared, 2 DF). Thus the Risk Model can also be used to make decisions regarding staged elective neck dissections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.